Molecules 2011, 16(3), 2146-2190; doi:10.3390/molecules16032146
Review

Antiplasmodial Natural Products

email and * email
Received: 25 January 2011; in revised form: 15 February 2011 / Accepted: 2 March 2011 / Published: 4 March 2011
(This article belongs to the Section Metabolites)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Malaria is a human infectious disease that is caused by four species of Plasmodium. It is responsible for more than 1 million deaths per year. Natural products contain a great variety of chemical structures and have been screened for antiplasmodial activity as potential sources of new antimalarial drugs. This review highlights studies on natural products with antimalarial and antiplasmodial activity reported in the literature from January 2009 to November 2010. A total of 360 antiplasmodial natural products comprised of terpenes, including iridoids, sesquiterpenes, diterpenes, terpenoid benzoquinones, steroids, quassinoids, limonoids, curcubitacins, and lanostanes; flavonoids; alkaloids; peptides; phenylalkanoids; xanthones; naphthopyrones; polyketides, including halenaquinones, peroxides, polyacetylenes, and resorcylic acids; depsidones; benzophenones; macrolides; and miscellaneous compounds, including halogenated compounds and chromenes are listed in this review.
Keywords: malaria; antimalarial; antiplasmodial; Plasmodium
PDF Full-text Download PDF Full-Text [390 KB, uploaded 18 June 2014 19:37 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Nogueira, C.R.; Lopes, L.M.X. Antiplasmodial Natural Products. Molecules 2011, 16, 2146-2190.

AMA Style

Nogueira CR, Lopes LMX. Antiplasmodial Natural Products. Molecules. 2011; 16(3):2146-2190.

Chicago/Turabian Style

Nogueira, Cláudio R.; Lopes, Lucia M. X. 2011. "Antiplasmodial Natural Products." Molecules 16, no. 3: 2146-2190.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert